Combined Cancer Immunotheranostic Nanomedicines: Delivery Technologies and Therapeutic Outcomes-Reference-Cited by-同舟云学术

Combined Cancer Immunotheranostic Nanomedicines: Delivery Technologies and Therapeutic Outcomes

Published:2023-01-27 Issue:5 Volume:8 Page:4491-4507
ISSN:2470-1343
Container-title:ACS Omega
language:en
Short-container-title:ACS Omega

Author:

Nasser Tasneem A.¹,Adel Rawan¹,Badr Abdelrahman¹,Teleb Mohamed¹²,Bekhit Adnan A.¹²,Elkhodairy Kadria A.¹³,Abdelhamid Ahmed S.¹,Elzoghby Ahmed O.¹³⁴^ORCID

Affiliation:

1. Cancer Nanotechnology Research Laboratory (CNRL), Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt

2. Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Alexandria University, Alexandria 5372066, Egypt

3. Department of Industrial Pharmacy, Faculty of Pharmacy, Alexandria University, Alexandria 5372066, Egypt

4. Division of Engineering in Medicine, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts 02115, United States

Publisher

American Chemical Society (ACS)

Subject

General Chemical Engineering,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acsomega.2c05986

Reference70 articles.

1. The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications

2. Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges

3. Metabolic barriers to cancer immunotherapy

4. The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications

5. The future of cancer immunotherapy: microenvironment-targeting combinations

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Theranostics as a Novel Strategy for Targeted Delivery of Therapeutics: Transport and Fate Mechanism, Challenge, and Opportunities;Nanotheranostics for Diagnosis and Therapy;2024

2. Fluorescent Chemo sensor nano-materials for Cancer bio-markers signalling: Towards development of non-invasive early detection strategies;Dyes and Pigments;2023-11

3. Unlocking Exosome-Based Theragnostic Signatures: Deciphering Secrets of Ovarian Cancer Metastasis;ACS Omega;2023-10-01

4. Patient-derived xenografts or organoids in the discovery of traditional and self-assembled drug for tumor immunotherapy;Frontiers in Oncology;2023-04-04